GV

Geetha Varadarajan

Director Director DIN 00440066
DIN 00440066 First appointment Mar 2003 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2003
Shareholding value Locked Premium profile

About Geetha Varadarajan

Data last updated:

Geetha Varadarajan has 23 years in corporate governance. Formerly with 1 company, such as Indian Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00440066
Primary Designation Director
First Appointment 27 Mar 2003
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director27 Mar 20031961Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indian Drugs And Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Geetha Varadarajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geetha Varadarajan

Geetha Varadarajan has 23 years in corporate governance. Formerly with 1 company, such as Indian Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Geetha Varadarajan is associated with 0 companies as a director.

Geetha Varadarajan has expertise in General Business.

Geetha Varadarajan has 23 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available